Form 10-Q · Quarterly report
TJX Companies 10-Q, filed Aug 28, 2026
- Filed
- CIK
- 0000109198
- Accession no.
- 0000109198-26-000048
Summary
TJX Companies said its second-quarter fiscal 2027 net sales rose 5% to $15.2 billion, with comparable sales up 4% and diluted EPS of $1.36, and that it received $331 million in IEEPA-related tariff refunds for a net benefit of $219 million after related bonus accruals. TJX also increased its long-term global store target to 7,500 stores and returned $1.3 billion to shareholders through share repurchases and dividends.
Key points
- Net sales for the quarter ended August 1, 2026 increased 5% to $15.2 billion, comparable sales rose 4%, and diluted EPS was $1.36 versus $1.10 a year earlier.
- TJX received $331 million of IEEPA-related tariff refunds, recording a $219 million net benefit after accruing $112 million for incremental year-end incentive compensation and discretionary bonuses.
- The U.S. Supreme Court invalidated IEEPA tariffs in February 2026, and TJX estimated it had paid approximately $490 million in such tariffs.
- TJX increased its long-term global store target to 7,500 stores and returned $1.3 billion to shareholders through share repurchases and dividends in the quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion OVERVIEW We are the leading off-price apparel and home fashions retailer in the U.S. and worldwide. Our mission is to deliver great value to our customers every day. We do this by selling a rapidly changing assortment of apparel, home fashions and other merchandise at prices generally 20% to 60% below full-price retailers’ (including department, specialty and major online retailers) regular prices on comparable merchandise, every day through our stores and six e-commerce sites. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.